Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory Mantle Cell Lymphoma: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9368-9372
10.1182/blood-2022-159425